Advanced search
Publication Cover
Leukemia & Lymphoma Volume 13, 1994 - Issue 5-6
Submit an article Journal homepage
48
Views
6
CrossRef citations to date
0
Altmetric
Original Article

An Aggressive High Dose Cyclophosphamide and Prednisone Regimen for Advanced Multiple Myeloma

R. E. Lenhard Johns Hopkins Oncology Center, Baltimore, Maryland
,
M. J. Daniels Dana-Farber Cancer Institute, Boston, Massachusetts
,
M. M. Oken Virginia Piper Cancer Institute, Minneapolis, Minnesota; Northwestern University Medical Center, Chicago, Illinois
,
J. H. Glick University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania
,
D. S. Ettinger Johns Hopkins Oncology Center, Baltimore, Maryland
,
L. Kalish Johns Hopkins Oncology Center, Baltimore, Maryland
&
M. J. O'connell Mayo Clinic, Rochester, Minnesota, USA
 show all
Pages 485-489 | Received 26 Jul 1993, Published online: 01 Jul 2009

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Donna E. Reece, Heather A. Leitch, Harold Atkins, Michael Voralia, Leah A. Canning, Richard LeBlanc, Andrew R. Belch, Darrell White & Michael J. Kovacs. (2008) Treatment of relapsed and refractory myeloma. Leukemia & Lymphoma 49:8, pages 1470-1485.
Read now

Articles from other publishers (5)

Young Trieu, Suzanne Trudel, Gregory R. Pond, Joseph Mikhael, Wilfrid Jaksic, Donna E. Reece, Christine I. Chen & A. Keith Stewart. (2005) Weekly Cyclophosphamide and Alternate-Day Prednisone: An Effective, Convenient, and Well-Tolerated Oral Treatment for Relapsed Multiple Myeloma After Autologous Stem Cell Transplantation. Mayo Clinic Proceedings 80:12, pages 1578-1582.
Crossref
Angela Dispenzieri, Martha Q. Lacy & Philip R. Greipp. 2004. Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders. Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders 53 109 .
Martin M. Oken, Traci Leong, Raymond E. Lenhard, Philip R. Greipp, Neil E. Kay, Brian Van Ness, Rudolph M. Keimowitz & Robert A. Kyle. (1999) The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma. Cancer 86:6, pages 957-968.
Crossref
Martin M. Oken. (2017) Management of Myeloma: Current and Future Approaches. Cancer Control 5:3, pages 218-225.
Crossref
Meletios A. Dimopoulos, Donna Weber, Hagop Kantarjian, Kay B. Delasalle & Raymond Alexanian. (1996) HyperCVAD for VAD-resistant multiple myeloma. American Journal of Hematology 52:2, pages 77-81.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.